Samsung Biologics announces strategic agreement with Bristol Myers Squibb
Samsung Biologics has officially announced a new agreement with Bristol Myers Squibb for large-scale manufacturing of a Bristol …
Samsung Biologics has officially announced a new agreement with Bristol Myers Squibb for large-scale manufacturing of a Bristol …
According to the latest information, Samsung Biologics secured the second position in the Most Trustworthy Companies in Healthcare and …
Samsung Biologics and Pfizer revealed a strategic partnership recently on June 8. This is for the long-term contract …
Samsung Biologics has reportedly got another patent lawsuit. Back in January, US pharmaceutical company Regeneron filed a patent …
In Q1 2023 Samsung Biologics recorded a revenue of KRW 720.9 billionand an operating profit of KRW 191.7 …
Samsung Biologics is a leading contract development and manufacturing organization (CDMO). It has received the Sustainable Markets Initiative’s …